Stryker Corporation (SYK) reported quarterly earnings results on Wednesday, Apr-20-2016. The company said it had a profit of $1.24 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.04. Analysts had a consensus of $1.20. The company posted revenue of $2495.00 million in the period, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.
Many Wall Street Analysts have commented on Stryker Corporation. Company shares were Downgraded by Robert W. Baird on Apr 13, 2016 to ” Neutral”, Firm has raised the Price Target to $ 116 from a previous price target of $111 .Barclays Resumed Stryker Corporation on Apr 11, 2016 to “Underweight”, Price Target of the shares are set at $107.Stryker Corporation was Initiated by Nomura to “Neutral” on Mar 17, 2016.
Stryker Corporation opened for trading at $109.76 and hit $110.52 on the upside on Monday, eventually ending the session at $110.39, with a gain of 0.54% or 0.59 points. The heightened volatility saw the trading volume jump to 10,39,660 shares. Company has a market cap of $41,174 M.
In a different news, on Apr 19, 2016, Ronda E Stryker (director) sold 12,000 shares at $109.89 per share price. According to the SEC, on Apr 5, 2016, Katherine Ann Owen (V.P., Strategy & Investor Rel.) sold 10,914 shares at $109.29 per share price. On Mar 15, 2016, Kevin Lobo (Chairman and CEO) sold 25,952 shares at $105.00 per share price, according to the Form-4 filing with the securities and exchange commission.
Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.